搜尋結果
PAGAC II-2 LIMITED. 1. Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or ...
公司註冊處處長登記前,不會向香港公眾人士提出要約或邀請。倘在適當時候向香港公眾人士提出要約或邀請,有意投資者務請僅依�. 於香港公司註冊處處長註冊的本公司招股章�. 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性或完整性亦不發表任何聲明,並明確表明概不就因本公告全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責任。 的要約,且亦非旨在邀請公眾人士認購或購買任何證券的要約。本�. 告不得被視為勸誘認購或購買任何證券,亦不擬構成該等勸誘�. 本公告僅為提供有關本公司的資料而刊發,概�. 任何其他目的。不應倚賴本公告所載資料作出任何投資決定。概不保證發售將會進行;任何證券發售均需要最終上�.
2 陳女士的履歷詳情載列如下： 陳維維女士，55 歲，於二零二零年十二月獲委任為本公司獨立非執行董事。陳女士於二零零四年二月加入賽諾菲集團，擔任首席財務官（中國）一職，其後自 二零一一年四月起擔任首席財務官（亞洲），直至其於二零一二年六月
monoclonal antibodies against human epidermal growth factor receptor 2 (HER2) target coupled with BB05. The Drug can bind to HER2-expressed tumor cells and endocytosis, releasing small molecule cytotoxic drugs (topoisomerase I inhibitors) in lysosomes
BACKGROUND. The Board announces that, during the period from 14 December 2022 to 27 December 2022, FriendTimes Technology (a wholly-owned subsidiary of the Company) entered into two Structured Deposit Agreements with Suzhou Branch of Shanghai Pudong Development Bank.
www1.hkexnews.hk
TERMINATION OF THE PLACING AGREEMENT. Reference is made to the announcement of DreamEast Group Limited (the “Company”, together. February 2024 and the circular of the Company dated26 February 2024 (the “Circular”) in relation t. the placing of new shares under specific mandate. Unless the context otherwise specified, capitalised terms ...
